cilostazol has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Demetter, P; Erneux, C; Hagué, P; Hockman, SC; Manganiello, VC; Vandenberghe, P; Vanderwinden, JM | 1 |
1 other study(ies) available for cilostazol and imatinib mesylate
Article | Year |
---|---|
Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST).
Topics: Aged; Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Synergism; Female; Gastrointestinal Stromal Tumors; HEK293 Cells; Humans; Imatinib Mesylate; Interstitial Cells of Cajal; Male; Mice, 129 Strain; Mice, Knockout; Middle Aged; Phosphodiesterase 3 Inhibitors; Pyridazines; Tetrazoles | 2017 |